miR-29b, also upregulated in SLE CD4+ T-cells, can negatively regulate DNMT1 expression by targeting SP1; further studies demonstrated that inhibition of miR-29a in the T-cells of SLE patients reversed DNA hypomethylation and the upregulation of downstream genes (34). The gene discussed is CD4; the disease is systemic lupus erythematosus.